Gabriel Holding A/S
19.3.2026 08:29:03 CET | Globenewswire | Press release
Implementation of mandate for Danske Bank to acquire shares from major shareholders (block trade)
Implementation of mandate for Danske Bank to acquire shares from major shareholders (block trade)
As announced in company announcement no. 2/2026, Gabriel Holding A/S has entered into an agreement with Danske Bank A/S that the bank, as lead manager, will be responsible for all trades under the share buy-back programme within the published framework. The share buy-back programme runs until 16 March 2027.
As also announced in Company Announcement No. 2/2026, Gabriel Holding A/S simultaneously granted Danske Bank A/S a discretionary mandate to explore and potentially acquire shares from major shareholders (block trades) during the term of the share buy-back programme. This mandate has been implemented with the following framework for Danske Bank A/S' acquisitions:
- Danske Bank A/S may purchase one or more blocks of a minimum of 2,500 shares at a price that does not exceed 5% of the last registered trading price, and
- Danske Bank A/S' purchases via block trades may not exceed 50% of the total published limit for Gabriel Holding A/S' share buy-back programme of 94,500 shares.
Gabriel Holding A/S may at any time suspend or terminate the share buy-back programme and Danske Bank A/S' discretionary mandate to execute block trades in connection therewith. This will be announced in a company announcement.
Gabriel Holding A/S will publish a company announcement every first of the month with a status of the buy-back programme in the form of the number of shares repurchased.
This is a translation of the original Danish text. In the event of discrepancies between the Danish and English texts, the Danish version shall prevail.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
F. Hoffmann-La Roche Ltd23.10.2026 19:30:00 CEST | Press release
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
TecDo Technology Co., Limited23.10.2026 18:37:22 CEST | Press release
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
CGTN23.10.2026 18:17:10 CEST | Pressemeddelelse
CGTN: Hvad fortæller historien om 'Half a Quilt' (Et halvt vattæppe) os om Kinas nye lange march?
Genmab A/S23.10.2026 17:55:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
Idorsia Pharmaceuticals Ltd23.10.2026 17:45:00 CEST | Press release
Idorsia presents outstanding results with daridorexant in children and adolescents with insomnia and an expanding body of evidence in adults at Sleep Europe 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom